Physician profile
Michael A Evans
NPI 1609127059
$4,896.95
in general payments reported to CMS, 2019-2025
22 companies · $868 in 2025
The $868 reported for 2025 was more than what 83% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $163 · 2021: $389 · 2022: $1,893 · 2023: $624 · 2024: $850 · 2025: $868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,286 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,285.56 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,242.07 | 2020-2024 | Xpress Loprofile, Audion Et Dilation System, Formula |
| Regeneron Healthcare Solutions, INC. | $907.54 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $751.32 | 2021-2025 | Nucala |
| Genzyme Corporation | $557.26 | 2020-2025 | |
| Optinose US, INC. | $445.15 | 2021-2023 | |
| Kaleo, INC. | $296.95 | 2019-2022 | |
| Inspire Medical Systems, INC. | $202.97 | 2023-2025 | Inspire |
| Smith+Nephew, INC. | $87.67 | 2025 | Coblation, Halo |
| Olympus America INC. | $69.16 | 2023 | Rhino-Laryngo Videoscope |
| Novartis Pharmaceuticals Corporation | $67.52 | 2021-2024 | |
| Pacira Pharmaceuticals Incorporated | $35.32 | 2025 | Exparel |
| Aerin Medical INC. | $33.00 | 2019-2020 | |
| Integra Lifesciences Corporation | $31.54 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Genentech USA, INC. | $27.34 | 2023 | Xolair |
| Ars Pharmaceuticals Operations, INC. | $25.32 | 2025 | Neffy |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $24.58 | 2020 | |
| Abbvie INC. | $23.81 | 2024 | |
| Osiris Therapeutics INC. | $15.16 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.88 | 2019 | |
| Medtronic, INC. | $13.70 | 2021 | |
| Intersect Ent, INC. | $13.48 | 2019 | |
| Karl Storz Endoscopy-America | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.